Blog
RSS FeedPosted by Michael Wonder on 25 Aug 2025
Bewildering PBAC decision a missed opportunity to ensure Australian cancer patients not left behind
23 August 2025 - MSD Australia & New Zealand is astonished that after eight years of dialogue and consideration, the ...
Posted by Michael Wonder on 25 Aug 2025
Recommendations made the PBAC – July 2025
22 August 2025 - The recommendations from the July 2025 PBAC meeting are now available. ...
Posted by Michael Wonder on 25 Aug 2025
Committee rejects application for medication Keytruda to be subsidised for Aussies with cancer
23 August 2025 - Australians with rare cancers like Natalie Willacy have just been handed a devastating hit, which could leave ...
Posted by Michael Wonder on 25 Aug 2025
Injectable form of Ocrevus for relapsing remitting multiple sclerosis recommended for PBS listing
22 August 2025 - This new form of ocrelizumab is given as an injection under the skin (subcutaneously), takes a much ...
Posted by Michael Wonder on 24 Aug 2025
New Alzheimer’s drug rejected for PBS listing, leaving patients to pay up to $80k a year
23 August 2025 - New Alzheimer’s drug rejected for PBS listing, leaving patients to pay up to $80k/year. ...
Posted by Michael Wonder on 20 Jun 2025
Recommendations made by the PBAC - May 2025
20 June 2025 - The recommendations from the May 2025 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 27 Apr 2025
Recommendations made by the PBAC – March 2025
24 April 2025 - Recommendations made by the PBAC in March 2025 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 25 Apr 2025
Multiple myeloma drug subsidised after treatment costs ballooned
24 April 2025 - It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely ...
Posted by Michael Wonder on 31 Jan 2025
Outcomes from the December 2024 PBAC meeting
31 January 2025 - Recommendations made by the PBAC in December 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 20 Dec 2024
Recommendations made by the PBAC – November 2024
20 December 2024 - Recommendations made by the PBAC in November 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 18 Oct 2024
Outcomes of the September 2024 PBAC intracycle meeting
18 October 2024 - The outcomes from the September 2024 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 25 Aug 2024
Recommendations made by the PBAC – July 2024
23 August 2024 - Recommendations made by the PBAC in July 2024 relating to the listing of medicines on the ...
Posted by Michael Wonder on 21 Jun 2024
Outcomes from the May 2024 PBAC intracycle meeting
21 June 2024 - Recommendations made by the PBAC in May 2024 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 29 Apr 2024
Life prolonging breast cancer drug recommended for PBS subsidy, but it is not time to celebrate
26 April 2024 - Breast Cancer Network Australia (BCNA) today welcomed a decision by the PBAC to recommend the life ...
Posted by Michael Wonder on 26 Apr 2024
Recommendations made by the PBAC (March 2024)
26 April 2024 - Recommendations made by the PBAC in March 2024 relating to the listing of medicines on the PBS ...